- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4174 - Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
Patent holdings for IPC class A61K 31/4174
Total number of patents in this class: 908
10-year publication summary
|
65
|
81
|
77
|
72
|
91
|
94
|
88
|
77
|
70
|
20
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2367 |
49 |
| Bioxcel Therapeutics, Inc. | 78 |
46 |
| Clexio Biosciences Ltd. | 101 |
11 |
| The Rockefeller University | 565 |
10 |
| Allergan Holdings Unlimited Company | 39 |
9 |
| Hisamitsu Pharmaceutical Co., Inc. | 771 |
9 |
| Bristol-myers Squibb Company | 4895 |
8 |
| F. Hoffmann-La Roche AG | 7900 |
8 |
| The Regents of the University of California | 19752 |
8 |
| Mitobridge, Inc. | 35 |
8 |
| EPI Health, LLC | 11 |
8 |
| Case Western Reserve University | 1787 |
7 |
| Galderma Research & Development | 406 |
7 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3357 |
7 |
| Orion Corporation | 609 |
7 |
| ARx, LLC | 22 |
6 |
| Cmpd Licensing, LLC | 77 |
6 |
| Mayne Pharma LLC | 24 |
6 |
| Nicox Ophthalmics, Inc. | 23 |
6 |
| St. Renatus, LLC | 11 |
6 |
| Other owners | 676 |